10/01/2026
🚀 Hot off the press: Mamedica featured in the
It’s encouraging to see medical cannabis reach the front pages this weekend, with Mamedica featured as part of the wider national conversation. At the same time, it’s disheartening when complex healthcare is presented without full clinical context.
At Mamedica, we remain focused on accuracy, regulation and patient-led evidence. Medical cannabis is a legal, clinician-prescribed option that millions worldwide turn to when conventional treatments have failed.
We will continue to inform and educate wider media discussions, helping ensure coverage reflects clinical reality as it enters the public domain.
Our priority is safe access, robust oversight and responsible care for people living with debilitating conditions.
🗞️ Read the full feature via the Daily Mail. Link in bio.